Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies ...

(UroToday.com) The 2025 European Society of Medical Oncology (ESMO) Annual Congress held in Berlin, Germany between September 17 th and 21 st was host to the session Mini oral session: GU tumours, ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...

Naïve B cells exit quiescence and enter a proliferative state upon activation, ultimately differentiating into antibody-secreting or memory B cells. Toll-like receptor (TLR) ligands, such as ...

作者：柏承志，官敏，徐华谦，单佳燕，黄爱萍，汤善宏西部战区总医院消化内科（四川省成都市金牛区）摘要胆管是维系胆汁代谢稳态、人体排泄的重要通道，其结构与功能完整对健康至关重要。临床实践中，药物毒性、自身免疫疾病、胆道梗阻、先天性胆汁酸转运蛋白基因突变、 ...

The skin, as the body’s largest organ, serves as a dynamic interface between internal systems and environmental influences.

Community-acquired pneumonia is a major global health challenge that disproportionately affects vulnerable populations, ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.